For instance, In April 2019, Ayanda received a patent for a soft gel capsule in Europe that can contain active probiotic germs. Before the innovation, the application of gels to bring probiotic bacteria was tough as the production of gels requires heats which did not enable bacteria to endure.
Glanbia PLC Abbott Bayer AG Pfizer Inc. Read This , Inc. Glaxo, Smith, Kline plc Bionova Ayanda Arkopharma Herbalife International of America, Inc. Nature's Sunshine Products, Inc. Market size value in 2022 USD 163. 9 billion Earnings projection in 2030 USD 327. 4 billion Growth Rate CAGR of 8.
Himalaya Global Holdings Ltd. Customization scope Complimentary report modification (equivalent approximately 8 expert's working days) with purchase. Addition or change to nation, local, and sector scope. Rates and purchase alternatives Avail tailored purchase options to satisfy your precise research needs. This report forecasts income growth at the international, regional, and nation levels and supplies an analysis of the most current industry trends in each of the sub-segments from 2017 to 2030.
Spain Asia Pacific China Japan Australia & New Zealand India Central & South America Middle East & Africa South Africa Saudi Arabia Often Asked Questions About This Report b. The primary ingredients used in the preparation of dietary supplements consist of minerals, vitamins, proteins, and amino acids, botanicals, omega fatty acids, and fibers, and specialty carbohydrates b.
9% from 2022 to 2030 to reach USD 327. 4 billion by 2030 b. The significant end-users in the dietary supplements market consist of adults, pregnant women, children, the geriatric population, and infants, with pregnant ladies expected to reveal significant product need through 2030 b. The non-prescription (OTC) type sector dominated the market with over 75.
0 
Star